Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kimberly D. Lockhart"'
Autor:
Elizabeth Ann Coleman, Kimberly D. Lockhart, Robert L. Kennedy, Sharon K. Coon, Carol Beth Stewart, Julia A. Goodwin, Bart Barlogie, Elias Anaissie, Clyde Bailey
Publikováno v:
Cancer. 118:549-557
BACKGROUND: Venous thromboembolism (VTE) is a significant but poorly understood complication in patients with newly diagnosed multiple myeloma (NDMM). As a result, most patients receive thromboprophylaxis with low molecular weight heparin (LMWH). The
Autor:
Nevada Copeland, Elizabeth Ann Coleman, Sharon K. Coon, Carol Beth Stewart, Shelia C. Savell, Paula McNatt, Robert L. Kennedy, Kimberly D. Lockhart, Robert Montgomery
Publikováno v:
JONA: The Journal of Nursing Administration. 40:S35-S42
The study compared certified nurses with noncertified nurses for symptom management of nausea, vomiting, and pain; patient satisfaction; and nurse satisfaction to determine the effect of certification in oncology nursing on those nursing-sensitive ou
Autor:
Bart Barlogie, Elias Anaissie, Sharon K. Coon, Elizabeth Ann Coleman, Robert L. Kennedy, Kimberly D. Lockhart, Carol Beth Stewart
Publikováno v:
Oncology Nursing Forum. 35:E53-E61
Purpose/objectives To determine the effect of aerobic and strength resistance training and epoetin alfa (EPO) therapy on transfusions, stem cell collections, transplantation recovery, and multiple myeloma treatment response. Design Randomized clinica
Autor:
Elias J, Anaissie, Elizabeth A, Coleman, Julia A, Goodwin, Robert L, Kennedy, Kimberly D, Lockhart, Carol B, Stewart, Sharon K, Coon, Clyde, Bailey, Bart, Barlogie
Publikováno v:
Cancer. 118(2)
Venous thromboembolism (VTE) is a significant but poorly understood complication in patients with newly diagnosed multiple myeloma (NDMM). As a result, most patients receive thromboprophylaxis with low molecular weight heparin (LMWH). The purpose of
Autor:
Carol Beth Stewart, Kimberly D. Lockhart, Robert L. Kennedy, Clyde Bailey, Elias Anaissie, Elizabeth Ann Coleman
Publikováno v:
Journal of Clinical Oncology. 27:9554-9554
9554 Background: DVT, a complication among newly diagnosed MM patients, is most common during the first 3–4 months of therapy. EPO, given to treat anemia in patients receiving chemotherapy, has been associated with increased DVT risk and the mechan
Autor:
Robert L. Kennedy, Elias Anaissie, Kimberly D. Lockhart, Elizabeth Ann Coleman, Sharon K. Coon, Bart Barlogie
Publikováno v:
Journal of Clinical Oncology. 24:8605-8605
8605 Background: Epoetin alfa increases hemoglobin levels and reduces the need for RBC transfusions in diverse groups of patients with cancer-related anemia. Interest in other potential benefits led to this study comparing outcomes relative to the du